1,2-Dichloroethane → HCID 58017527, compound
Reaction equation
[O:1]1[CH2:5][CH2:4][C@@H:3]([C:6]([O:8]CC)=O)[N:2]1[C:11]([O:13][C:14]([CH3:17])([CH3:16])[CH3:15])=[O:12].[OH-].[Li+].Cl.[Cl:21][C:22]1[CH:23]=[CH:24][C:25]([N:30]2[CH:34]=[N:33][N:32]=[N:31]2)=[C:26]([CH:29]=1)[CH2:27][NH2:28].OC1C2N=NNC=2C=CC=1.C(Cl)CCl.CN1CCOCC1>C(#N)C.O.C(Cl)Cl>[Cl:21][C:22]1[CH:23]=[CH:24][C:25]([N:30]2[CH:34]=[N:33][N:32]=[N:31]2)=[C:26]([CH:29]=1)[CH2:27][NH:28][C:6]([C@@H:3]1[CH2:4][CH2:5][O:1][N:2]1[C:11]([O:13][C:14]([CH3:15])([CH3:16])[CH3:17])=[O:12])=[O:8]Participants
Reactant 6
Product 1
Reagents, catalysts & solvents 3
Procedure
To a solution of 2-tert-butyl 3-ethyl (3S)-isoxazolidine-2,3-dicarboxylate (245 mg, 1.00 mmol) in acetonitrile (2.5 mL) and water (1 mL) was added lithium hydroxide (1 M in water, 1.00 mL, 1.00 mmol) and the mixture was stirred at rt for 30 min. To this solution was added 5-chloro-2-tetrazol-1-yl-benzylamine hydrochloride (295 mg, 1.20 mmol, prepared as described in J. Med. Chem. 2004, 47, 2995), hydroxybenzotriazole (135 mg, 1.00 mmol, as a 20% solution in water, ca 0.65 mL), EDC (288 mg, 1.50 mmol) and NMM (202 mg, 2.00 mmol). The resulting mixture was stirred at rt over night, then diluted with DCM and washed with 1 M HCl and saturated sodium hydrogen carbonate. The organic phase was dried, filtered, evaporated and purified by flash chromatography (DCM/EtOAc gradient from 4:1 to 1:1) to give tert-butyl (3S)-3-{[5-chloro-2-(1H-tetrazol-1-yl)benzyl]carbamoyl}isoxazolidine-2-carboxylate (357 mg, 87%) as an oil.
Workup
- stirringThe resulting mixture was stirred at rt over night
- washwashed with 1 M HCl and saturated sodium hydrogen carbonate
- customThe organic phase was dried
- filtrationfiltered
- customevaporated
- custompurified by flash chromatography (DCM/EtOAc gradient from 4:1 to 1:1)
Sources & evidence
- ORD record
- ord-b4e73c52171e4651b39f74f4fc2f4cb8
- Source dataset
- uspto-grants-2012_02
- Patent number
- US08119673B2
Reaction notes
Loading…